Singleton Mark Leonard bought BVS
March 21, 2024 · Form 4 insider transaction
Singleton Mark Leonard bought 18,625 shares of Bioventus Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,625
Price
N/A
Total value
N/A
InsiderSingleton Mark Leonard
Role—
CompanyBioventus Inc. (BVS)
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateMarch 21, 2024
Filing dateMarch 25, 2024
Shares owned after31,206
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.